Ilsung Pharm Cash Flow Quality Index
Ilsung Pharm cash flow quality index. Ilsung Pharm (003120) has a Cash Flow Quality Index of 0.57x as of June 2026. Operating cash flow of ₩124.28 Million is below net income of ₩216.95 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of Ilsung Pharm to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Ilsung Pharm (2013–2025)
Cash flow quality index of Ilsung Pharm from 2013 to 2025. Historical Cash Flow Quality Index for Ilsung Pharm across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Ilsung Pharm (003120) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Ilsung Pharm Cash Flow Quality Index by Year (2013–2025)
Ilsung Pharm cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for Ilsung Pharm. For the full cash flow conversion analysis, see how efficiently does Ilsung Pharm generate cash.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.33x | ₩3.88 Billion | ₩1.17 Billion | ▲ +1124.3% |
| 2024 | -0.33x | ₩-4.26 Billion | ₩13.09 Billion | ▲ +12.2% |
| 2022 | -0.37x | ₩-38.97 Billion | ₩105.24 Billion | ▼ -176.6% |
| 2020 | 0.48x | ₩1.56 Billion | ₩3.22 Billion | ▼ -26.0% |
| 2019 | 0.65x | ₩4.39 Billion | ₩6.72 Billion | ▼ -87.3% |
| 2018 | 5.12x | ₩15.09 Billion | ₩2.95 Billion | ▲ +32.6% |
| 2017 | 3.86x | ₩10.16 Billion | ₩2.63 Billion | ▲ +137.6% |
| 2016 | -10.28x | ₩-31.01 Billion | ₩3.02 Billion | ▼ -16919.6% |
| 2015 | 0.06x | ₩6.04 Billion | ₩98.85 Billion | ▼ -94.1% |
| 2014 | 1.04x | ₩4.19 Billion | ₩4.03 Billion | ▲ +63.2% |
| 2013 | 0.64x | ₩5.06 Billion | ₩7.96 Billion | — |